PharmiWeb Today Story
London, 15 May 2025 – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, is today hosting sell-side analysts and investors at its US manufacturing and R&D facility in Columbus, Ohio. The senior leadership teams from our Generics and Injectables segments will present on their respective businesses, strategies, and plans to deliver long-term, sustainable growth.
Attendees will tour the Group's state-of-the-art, 1,000,000 sq. ft. facility in Columbus, which produces oral, respiratory and other generic and specialty products. It is one of Hikma's four US manufacturing facilities producing a broad range of medicines for patients across the US, where Hikma is one of the largest suppliers of generic medicines. Attendees will also tour the Company's newly acquired Injectables facility in Bedford, Ohio.
Alongside the event, Hikma is introducing the following medium-term guidance:
- Group revenue growth - 6% to 8% three-year CAGR (2024 to 2027)
- Group core operating profit growth - 7% to 9% three-year CAGR (2024 to 2027)
In addition, Hikma is introducing a five-year target for Group revenue to reach $5 billion by 2030.
Hikma is also announcing that its Generics business is being renamed Hikma Rx to reflect its focus on providing differentiated and complex prescription (Rx) medicines.
The presentation is available on Hikma's website at https://www.hikma.com/investors/results-and-presentations/. A recording and transcript of the presentation and Q&A will be made available following the event.
Read More...
Articles

What Does a Pharmaceutical Account Manager Do?
04-Mar-2025

Top 10 Highest Paying Pharma Jobs in 2025
18-Feb-2025

The Impact of AI on Pharmaceutical Sales
13-Feb-2025

What Does a Medical Science Liaison Do?
18-Sep-2023
Featured Events

-
1st International Conference “WE! are the Clinical…
18-Sep-2021 - 18-Sep-2021 -
Reuters Events: Cell & Gene Therapy USA 2021
28-Sep-2021 - 29-Sep-2021 -
Pharmaceutical Manufacturing and Packaging Congres…
20-Jun-2022 - 21-Jun-2022 -
How to impact, influence & inspire
07-Feb-2023 - 21-Feb-2023 -
Genomics and Precision Medicine Expo
23-May-2023 - 24-May-2023 -
Global Biomanufacturing Summit
25-May-2023 - 26-May-2023
News

-
Formycon and Fresenius Kabi announce FDA Approval…
19-May-2025 -
Emergency Care Partners Establishes a New Partner…
19-May-2025 -
Repair Biotechnologies Receives Orphan Drug Design…
19-May-2025 -
Sinceri Senior Living Earns Great Place to Work Ce…
19-May-2025 -
CrossTx Inc. Selected by EverCare Mobile Health to…
19-May-2025 -
CLS Health and Houston Food Bank Unite to Fight Hu…
19-May-2025